Filgrastim-Stimulated Bone Marrow Compared with Filgrastim-Mobilized Peripheral Blood in Myeloablative Sibling Allografting for Patients with Hematologic Malignancies: A Randomized Canadian Blood and Marrow Transplant Group Study

Stephen Couban, Mahmoud Aljurf, Sylvie Lachance, Irwin Walker, Cynthia Toze, Morel Rubinger, Jeffrey H. Lipton, Stephanie J. Lee, Richard Szer, R. Doocey, Ian D. Lewis, Lothar Huebsch, Kang Howson-Jan, Michel Lalancette, Fahad Almohareb, Nadeem Chaudhri, Sabine Ivison, Raewyn Broady, Megan Levings, Diane FaircloughGerald Devins, David Szwajcer, Ronan Foley, Clayton Smith, Tony Panzarella, Holly Kerr, Amina Kariminia, Kirk R. Schultz

Research output: Contribution to journalArticlepeer-review

24 Citations (Scopus)
Original languageEnglish
Pages (from-to)1410-1415
Number of pages6
JournalBiology of Blood and Marrow Transplantation
Volume22
Issue number8
DOIs
Publication statusPublished - Aug 1 2016
Externally publishedYes

ASJC Scopus Subject Areas

  • Transplantation
  • Hematology

Keywords

  • Blood and marrow transplantation
  • Donor source
  • Filgrastim
  • Graft-versus-host disease
  • Hematopoietic cell transplantation
  • Mobilized bone marrow

Fingerprint

Dive into the research topics of 'Filgrastim-Stimulated Bone Marrow Compared with Filgrastim-Mobilized Peripheral Blood in Myeloablative Sibling Allografting for Patients with Hematologic Malignancies: A Randomized Canadian Blood and Marrow Transplant Group Study'. Together they form a unique fingerprint.

Cite this